Al's Comment:

 This is a new modality of treatment - antisense oligonucleotides. It worked for spinal muscular atrophy - which proves it can get and stay in the brain and spinal cord and make a big difference.  They are now doing preclinical work on DIPG.   We (The Musella Foundation) gave him his first grant to get started with DIPG back in 2016! Hopefully this will not only make a difference in DIPG, but the technology could be altered to work on most mutations. 


Posted on: 04/13/2023

From Tragedy to Triumph: A Promising New Treatment for Pediatric Brain Cancer

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!